A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer treatment without chemotherapy.

In this piece, we will discuss the 10 Most Active Penny Stocks to Buy. The 2026 Iran conflict has resulted in a spike in ...

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.

A biomimetic microparticle designed to recruit and reactivate CAR-iNKT cells, helping sustain cancer-fighting activity. Credit: Haochen Nan and Song Li/UCLA A tiny implant may give cancer-fighting ...

Plus: Parkland Health selected for Nation Workforce Well-Being Initiative, Plano-based Percipio Health joins American Heart Association Innovators Network, and more.

Universal month-3 NGF MRD negativity (10⁻⁵) followed short-course VRd or daratumumab-based induction and single-infusion YK-hBCMA BB-002, despite high-risk biology and frailty representation. Depth of ...

Foundational research led by co-founder Justin Eyquem, Ph.D., underpins Azalea’s proprietary in vivo CAR T platformPeer-reviewed publication demonstrates stable, cell-specific transgene expression ...

The powerful gene-editing technique CRISPR–Cas9 might offer a way to make safer, more effective cancer-fighting immune cells ...

A mouse study shows CAR-T cells can be engineered in vivo with precise gene editing, a potential breakthrough that could cut ...

Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy for cancers that form solid tumors, including ...

Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and immunoediting compared with single-pathway CAR-T constructs. Complete tumor ...

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...